by Jessica Casebolt | Mar 17, 2023 | Access & Coverage, Tea Leaves
French pharmaceutical company Sanofi, one of the top three insulin manufacturers for the U.S., announced on Thursday it would be cutting the list price for its most prescribed insulin product, Lantus, by 78 percent, joining fellow major insulin manufacturers in...
by Jessica Casebolt | Mar 16, 2023 | Access & Coverage, Tea Leaves
The judge in a closely watched lawsuit seeking to overturn federal approval of a widely used abortion pill questioned lawyers publicly for the first time yesterday. The wide-ranging hearing included discussion about whether the anti-abortion plaintiffs had the legal...
by Jessica Casebolt | Mar 15, 2023 | Access & Coverage, Tea Leaves
Yesterday, fourteen Democratic governors asked seven leading pharmacy retailers to clarify their plans for dispensing mifepristone, a pill used in medication abortions. The move comes shortly after Walgreens announced that it would not dispense mifepristone in some...
by Jessica Casebolt | Mar 14, 2023 | Access & Coverage, Tea Leaves
The Veterans Health Administration (VHA) announced yesterday that it intends to pay for the experimental Alzheimer’s drug, Leqembi, that the Centers for Medicare and Medicaid Services has to date declined to cover. The decision by VHA stands in contrast with...
by Jessica Casebolt | Mar 10, 2023 | Access & Coverage, Tea Leaves
States can restart Medicaid redeterminations in less than a month, and a new coalition aims to avoid coverage lapses for people who may be culled from the program. The Connecting to Coverage Coalition is spearheaded by AHIP, the health insurance industry’s...
by Jessica Casebolt | Mar 9, 2023 | Access & Coverage, Tea Leaves
A new survey from Morning Consult found that patients will likely avoid preventive care if the courts dismantle a list of no-cost preventive care services under the Affordable Care Act (ACA). The organization polled a representative sample of 2,199 adults and found...
Recent Comments